ASSESSMENT OF DIFFERENT REGIMENS OF DIPHTHERIA SEROTHERAPY


Cite item

Full Text

Abstract

Aim. Efficacy of different treatment regimens with equine diphtheria antitoxin (EDA) was assessed on clinical samples as well as in experiments on animals. Materials and methods. Protective properties and serum concentration kinetics of heterologous antibod- ies was studied on 12 rabbits and 51 guinea pigs after intramuscular injection of different doses of EDA, in serum samples from 26 patients, which received one intramuscular injection of EDA in various doses as well as in serum samples from 10 patients with diphtheria of different severity, which were treated with EDA in total course dose 100.000 - 1.500.000 IU. Antitoxin concentration in serum sample was measured with passive hemagglutination assay as well as Jensen toxin neutralization test on rabbits. Results. Experiments on laboratory animals received EDA in dose 150 IU/kg showed high protective effect. For example, rabbits with antitoxin level 1.0 - 1.25 IU/ ml in serum 24 hours after injection of EDA were 50 - 250 times resistant to dermonecrotic effect of diphtheria toxin compared with rabbits not received EDA. Guinea pig with antitoxin level 0.5 - 2.0 IU/ ml in serum 24 - 48 hours after injection of EDA in dose 150 IU/kg were all protected against 35 - 50 LD 50 of diphtheria toxin. After termination of EDA injection there was sharp decrease of antitoxin level and it was not detected in serum 7 days after. Increase of antitoxin level in serum of animals was not adequate to quantity of injected EDA. Study of serum samples from 26 patients received one intramuscular injec- tion of different doses of EDA showed that doses of antitoxin from 20.000 to 30.000 IU resulted in its presence in serum in concentration 0.5 - 3.0 IU/ml whereas injection of 50.000 IU or 70.000 - 100.000 IU resulted in serum concentrations 1.25 - 10.0 IU/ ml and 2.5 - 20.0 IU/ml respectively. Conclusion. Relatively low doses of EDA provided relatively high level of protection against diphtheria toxin that should be taken into account during treatment of diphtheria patients.

About the authors

A. G Matokhina

Central Research Institute of Epidemiology, Moscow, Russia

V. A Kapustyan

Tarasevich State Institute for Standrdization and Control of Medical Biological Preparations,Moscow,Russia

O. V Perelygina

Central Research Institute of Epidemiology, Moscow, Russia

References

  1. Кравченко А.Т., Резепов Ф.Ф. К вопросу о механизме действия антитоксических сыво- роток. Научные основы производства бактерийных препаратов. Бюро научной информации. М., 1961, Х: 137-150.
  2. Маркина С.С., Максимова Н.М., Лазикова Г.Ф. Заболеваемость дифтерией в России в настоящее время. Журн. микробиол. 2005, 1: 31-37.
  3. Ценева Г.Я., Рыкушин Ю.П., Быстрякова Л.В. Дифтерия (эпидемиология, клиника, лабораторная диагностика). СПб, 1995.
  4. Klöppel U. Enacting cultural boundaries in French and German diphtheria serum research. Science in Context. 2008, 2: 161-180.
  5. Opinel A. The Pasteur Hospital as an element of Emile Roux's anti-diphtheria apparatus (1890- 1914). Dynamis. 2007, 27: 83-106.

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2010 Matokhina A.G., Kapustyan V.A., Perelygina O.V.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: ПИ № ФС77-75442 от 01.04.2019 г.


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies